Non-motor features of Parkinson disease
- PMID: 28592904
- DOI: 10.1038/nrn.2017.62
Non-motor features of Parkinson disease
Erratum in
-
Non-motor features of Parkinson disease.Nat Rev Neurosci. 2017 Aug;18(8):509. doi: 10.1038/nrn.2017.91. Epub 2017 Jul 13. Nat Rev Neurosci. 2017. PMID: 28720825
Abstract
Many of the motor symptoms of Parkinson disease (PD) can be preceded, sometimes for several years, by non-motor symptoms that include hyposmia, sleep disorders, depression and constipation. These non-motor features appear across the spectrum of patients with PD, including individuals with genetic causes of PD. The neuroanatomical and neuropharmacological bases of non-motor abnormalities in PD remain largely undefined. Here, we discuss recent advances that have helped to establish the presence, severity and effect on the quality of life of non-motor symptoms in PD, and the neuroanatomical and neuropharmacological mechanisms involved. We also discuss the potential for the non-motor features to define a prodrome that may enable the early diagnosis of PD.
Similar articles
-
Premotor Diagnosis of Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3. Neurosci Bull. 2017. PMID: 28776303 Free PMC article. Review.
-
Non-motor symptoms in Parkinson's disease.Eur J Neurol. 2008 Apr;15 Suppl 1:14-20. doi: 10.1111/j.1468-1331.2008.02056.x. Eur J Neurol. 2008. PMID: 18353132 Review.
-
[Non-motor symptoms in premotor phase of Parkinson disease].Rinsho Shinkeigaku. 2013;53(11):974-6. doi: 10.5692/clinicalneurol.53.974. Rinsho Shinkeigaku. 2013. PMID: 24291850 Review. Japanese.
-
Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.Arch Pharm Res. 2021 Jun;44(6):588-604. doi: 10.1007/s12272-021-01337-3. Epub 2021 Jun 19. Arch Pharm Res. 2021. PMID: 34145553 Free PMC article. Review.
-
The relevance of pre-motor symptoms in Parkinson's disease.Expert Rev Neurother. 2015 Oct;15(10):1205-17. doi: 10.1586/14737175.2015.1083423. Epub 2015 Sep 1. Expert Rev Neurother. 2015. PMID: 26416397 Review.
Cited by
-
The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease.Cells. 2021 Mar 6;10(3):579. doi: 10.3390/cells10030579. Cells. 2021. PMID: 33800736 Free PMC article. Review.
-
Clinical assessment and striatal dopaminergic activity in healthy controls and patients with Parkinson's disease: a Bayesian approach.Ann Nucl Med. 2024 Dec;38(12):989-998. doi: 10.1007/s12149-024-01972-y. Epub 2024 Aug 27. Ann Nucl Med. 2024. PMID: 39190111
-
Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson's disease.Neuronal Signal. 2018 Jan 26;2(1):NS20170181. doi: 10.1042/NS20170181. eCollection 2018 Mar. Neuronal Signal. 2018. PMID: 32714583 Free PMC article.
-
Recent developments in nucleic acid-based therapies for Parkinson's disease: Current status, clinical potential, and future strategies.Front Pharmacol. 2022 Oct 20;13:986668. doi: 10.3389/fphar.2022.986668. eCollection 2022. Front Pharmacol. 2022. PMID: 36339626 Free PMC article. Review.
-
Exploring Parkinson's Disease-Associated Depression: Role of Inflammation on the Noradrenergic and Serotonergic Pathways.Brain Sci. 2024 Jan 20;14(1):100. doi: 10.3390/brainsci14010100. Brain Sci. 2024. PMID: 38275520 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical